Effect of dietary soy isoflavone aglycones on the urinary 16α-to-2-hydroxyestrone ratio in C3H/HeJ mice

Nutrition and Cancer

Volumn 38, Issue 2, 2000, Pages 209-214

  Kishida, T ^a   Beppu, M ^a   Nashiki, K ^a   Izumi, T ^a   Ebihara, K ^a  

^a EHIME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 3 INDOLEMETHANOL; CYTOCHROME P450; DAIDZEIN; ESTRADIOL; GENISTEIN; ISOFLAVONE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; LIVER MICROSOME; LIVER WEIGHT; MOUSE; NONHUMAN; SOYBEAN; URINARY EXCRETION;

ANIMALIA; GLYCINE MAX;

EID: 0034434443     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC382_10     Document Type: Article

References (43)

1. Experimental downregulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells
2. Induction by the estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells
3. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: Studies using Syrian hamster embryo cells treated with 17β-estradiol and eight of its metabolites
4. Upregulation of estradiol C16α-hydroxylation in human breast tissue: A potential biomarker of breast cancer risk
5. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans
6. Effects of pesticides on the ratio of 16α-hydroxyestrone: A biologic marker of breast cancer risk
7. 2-Hydroxyestrone: The "good" estrogen
8. Estradiol metabolism: An endocrine biomarker for modulation of human mammary carcinogenesis
9. Oestradiol 16α-hydroxylase: A risk marker for breast cancer
10. The role of estrogen in mammary carcinogenesis
11. Increased estrogen-16α-hydroxylase activity in women with breast and endometrial cancer
12. Abnormal oxidative metabolism of estradiol in women with breast cancer
13. Monoclonal antibodybased enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine
14. Urinary 2/16α-hydroxyestrone ratio: Correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk
15. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women
16. 1) in postmenopausal women with and without breast cancer
17. Induction of 16α-/2-hydroxyestrone metabolite ratios in MCF-7 cells by pesticides, carcinogens, and antiestrogens does not predict mammary carcinogens
18. Soybeans inhibit mammary tumors in models of breast cancer
19. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones
20. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
21. Long-term responses of women to indole-3-carbinol or a high fiber diet
22. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol
23. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies
24. Synthesis and labeling of isoflavone phytoestrogens, including daidzein and genistein
25. The carbon monooxide binding pigment of liver: Evidence for its hemoprotein nature, solubilization, purification and properties
26. Protein measurement with the Folin phenol reagent
27. Biological responses of young rats fed diets containing genistin and genistein
28. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors α and β in vitro
29. Increased urinary excretion of 2-hydroxyestrone but not 16α-hydroxyestrone in premenopausal women during a soya diet containing isoflavones
30. Aromatic hydroxylation of estrogens
31. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin
32. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation
33. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice
34. Interaction between a semisynthetic diet and indole-3-carbinol on mammary tumor incidence in Balb/cfC3H mice
35. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol
36. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol
37. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans
38. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells
39. Growth inhibition of human breast cancer cells by herbs and phytoestrogens
40. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones
41. 3,3′, 4,4′-tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in the rat
42. Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals
43. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides